This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The long-awaited PDA TR 43 report provides an approach to a quality decision-making process and represents best practices for the identification and classification of visual nonconformities for (empty) glass containers as pharmaceuticalproduct packaging.
Additionally, this can be caused by “poor handling, repackaging, and nonadherence to good manufacturing practices [GMP] during dispensing and packaging have resulted in the microbiological contamination of non-sterile pharmaceuticalproducts.” According to the authors, these were linked to 55 fatal cases of fungal meningitis.
Patents are often described as the ‘lifeblood’ of pharmaceutical companies. 1 However, patent protection for pharmaceuticalproducts is an economic trade-off between providing monopoly rights that incentivise development of future products and permitting higher drug prices to recoup the investment. 23 April 2013.
For at least a decade from 2013 until recently, LDL lowering treatments were stuck on a paradigm of just putting people on statins and not getting LDL levels down to certain goals” CETP inhibitors have been around for a while, but they have unfortunately been unsuccessful in getting onto the market commercially. “For
The other side is the pipeline of new pharmaceuticalproducts. Prior to November 2013 he worked for Merck Research Laboratories in Summit, New Jersey as the Senior Principal Scientist in early phase drug development. About the authors. Dr Tony Cundell has a PhD in Microbiology from the Lincoln University, New Zealand.
TRS 953 – Annex 2, Appendix 1: Stability testing of active pharmaceutical ingredients and finished pharmaceuticalproducts: Stability conditions for WHO Member States by Region. 2011;29:7122–7124. Sharma D, Khamar S, Cullen A, et al. Innovative Drying Technologies for Biopharmaceuticals. Int J Pharm. US10821210B2 Injections.
ICH Guideline Q12 On Technical And Regulatory Considerations For PharmaceuticalProduct Lifecycle Management. ICH Guideline Q13 On Continuous Manufacturing Of Drug Substances And Drug Products – Scientific Guideline. EMA/CHMP/ICH/353369/2013. EMA/CHMP/ICH/83812/2013. November 2012. EMA/CHMP/ICH/425213/2011.
Q12 Technical and Regulatory Considerations for PharmaceuticalProduct Lifecycle Management. Q13 Continuous Manufacturing of Drug Substances and Drug Products. International Cooperation, Convergence And Harmonization Of Pharmaceutical Regulations: A Global Perspective. International Council for Harmonisation (ICH), 2019.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content